United States · FDA National Drug Code directory
Xylocaine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70518-4152_5a0cdbe5-4925-e187-e063-6294a90a00f1
- Product NDC
- 70518-4152
- Form
- INJECTION, SOLUTION
- Composition / generic term
- LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE
- Labeler
- REMEDYREPACK INC.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240731
- Source listing expiry
- 20271231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE ANHYDROUS — 10 mg/mL
- EPINEPHRINE BITARTRATE — .01 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL, MULTI-DOSE in 1 TRAY (70518-4152-1) / 20 mL in 1 VIAL, MULTI-DOSE (70518-4152-0) · 70518-4152-1
- 25 VIAL, MULTI-DOSE in 1 TRAY (70518-4152-2) / 50 mL in 1 VIAL, MULTI-DOSE (70518-4152-3) · 70518-4152-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →